&nbsp;

FITKitInstructions-Slovak.pdf

Dec 2023

Document

FITKitInstructions-Dari.pdf

Dec 2023

Document

FITKitInstructions-Pashto.pdf

Dec 2023

Guidelines and Advice

Fear of Cancer Recurrence Guideline

Status: Current
ID: GL 19-7

Mar 2024

Fumika Test Page (FR)

This is FR page

Regimen

FLAG+IDA+VENE

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Curative

Drugs Used:

IDArubicin,

fludarabine,

cytarabine,

venetoclax (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Jul 2024

Regimen

FRUQ

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Drugs Used:

fruquintinib (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Oct 2024

Guidelines and Advice

First-line treatment of advanced-stage Hodgkin lymphoma

Status: Current
ID: ES 6-25

Oct 2024

Regimen

XELOX+PEMB+TRAS

Cancer Type:

Gastrointestinal,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma

ODB - General Benefit

capecitabine

New Drug Funding Program

Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

FOLFIRI

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2024

Document